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ABSTRACT
One of the most important events related to drug interactions is the ability of
some drugs to induce hepatic microsomal monooxygenases and to increase the
toxicity of other drugs. A single intraperitoneal dose of thioacetamide was
administered to rats (500 mg/Kg) to induce liver necrosis and regeneration; and on
this experimental model the influence of intraperitoneal phenobarbital
administration (80 mg/Kg/day) for five days before thioacetamide was studied. The
results show that phenobarbital pre-treatment increased liver damage induced by
thioacetamide, as detected by increases in serum enzymatic activities, levels of
total bilirubin, and by the extent of the necrotic area in the perivenous acinar
region. The higher liver injury was parallel to the higher rate of tissue regenerative
response as demonstrated by the rate of DNA synthesis in hepatocytes and the level
of α-fetoprotein in serum. We can conclude that phenobarbital pre-treatment
enhanced hepatotoxicity and hepatocellular regeneration, but did not change either
acinar location or timing of liver injury and regeneration induced by thioacetamide.
Moreover, the proliferative response as well as the changes in diploid and polyploid
populations, were more pronounced in phenobarbital pretreated hepatocytes.
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RESUMEN
El pretratamiento con fenobarbital incrementa la necrosis
y la regeneración postnecrótica inducida por tioacetamida
Uno de los aspectos más importantes de las interacciones de fármacos es la
habilidad de algunos de ellos de inducir las monooxigenasas microsomales hepá-
ticas e incrementar la toxicidad de otras drogas. Se administró a las ratas una
dosis única de tioacetamida por vía intraperitoneal (500 mg/Kg de peso) para
provocar una necrosis y regeneración hepática; sobre este modelo experimental se
estudió la influencia de la administración intraperitoneal de fenobarbital (80 mg/
Kg/día) durante los cinco días previos a la administración de la tioacetamida. Los
resultados muestran que el pretratamiento con fenobarbital incrementó el daño
hepático provocado por la tioacetamida, como se demuestra por los incrementos
de las actividades enzimáticas en suero, niveles totales de bilirrubina y por la
extensión del área necrótica en la región acinar perivenosa. Este mayor daño
hepático fue paralelo al incremento de la respuesta regenerativa del tejido como
queda demostrado por el aumento de la síntesis de DNA y por el nivel de α-fe-
toproteína en suero. Podemos concluir que el pretratamiento con fenobarbital
aumenta la hepatotoxicidad y la regeneración hepatocelular, sin embargo, no mo-
difica ni la localización acinar ni el patrón temporal del daño hepático y regene-
ración inducida por la tioacetamida. Además, tanto la respuesta proliferativa como
los cambios en las poblaciones diploides y poliploides, fueron más pronunciados
en los hepatocitos pretratados con fenobarbital.
Palabras clave: Fenobarbital.—Tioacetamida.—Daño hepático.—Regeneración
hepática.
INTRODUCTION
It is well known that phenobarbital (PB) induces P450-dependent
metabolic processes in liver tissue (1, 2). This inductive response has
a major impact on drug interactions (3, 4). Thus, PB potentiates the
hepatotoxicity of cocaine by increasing the severity of liver damage
and shifting the intraacinar injury from the perivenous to the
periportal area of the liver acini (3). PB also potentiates the
hepatotoxicity of thioacetamide and enhances the activity of flavin-
containing monooxygenase (4). Infliction of toxicant-induced injury
is accompanied by a parallel tissue repair stimulation response,
which allows the organism to overcome the injury up to a threshold
dose. Beyond this threshold, a diminished or delayed tissue repair
response allows an unrestrained progression of injury. The
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stimulation of liver repair through hepatocyte proliferation has been
shown to permit the recovery from massive and normally lethal liver
injury. The concept of toxicodynamic interaction between inflicted
injury and stimulated tissue repair offers opportunity to fine-tune
many pharmacological aspects.
Thioacetamide (TA) is a potent hepatotoxic agent which, when
administered at doses of 500 mg/Kg to rats, originates a severe
hepatocellular perivenous necrosis (5, 6). The initiation of the chain
of cellular events leading to TA-induced liver necrosis is due to the
generation of reactive metabolites: S-oxide and sulfone, obligatory
intermediates in the process of microsomal oxidation of TA (7-9).
The selective destruction of perivenous hepatocytes and the
immediate proliferative state of the remaining liver cells, have been
used as an experimental model by which to study the hepatic
response against the aggressive attack of a hepatotoxic drug. Thus,
this response presents a double aspect: the hepatocellular necrosis
and the post-necrotic regeneration linked to the restoration of liver
function (10, 11).
Phenobarbital (PB) induces efficiently the transcription of several
isoforms of cytochrome P450 (12), and, consequently, has the ability
to enhance the activity of hepatic drug metabolizing enzymes, which
can result in the increased metabolism and toxicity of drugs (2, 13).
The aim of the present study was to clarify experimentally
whether PB, potentiating the hepatotoxicity and the amplification of
the hepatic injury induced by TA, also affects the proliferative
regenerating state immediately triggered following the necrosis, as
well as to visualize the location and extent of the necrotic area on
liver slices. Accordingly, rats were treated or not with PB for five
days previous to administration of TA. To follow the time course of
events, samples of blood, liver and hepatocytes were obtained at 0,
12, 24, 48, 72 and 96 h of TA intoxication. Morphological study,
parameters of liver injury, and those related to TA metabolism were
obtained. The proliferative post-necrotic response was assayed by
evaluating the mitotic index on glass slide mounted sections of liver,
as well as by determining the serum levels of a-fetoprotein and the
ploidy and DNA distribution in the cell cycle phases in isolated
hepatocytes by flow cytometry.




Enzymes and collagenase were obtained from Boehringer
Mannheim. Substrates, coenzymes and propidium iodide were from
Sigma Chemical. Standard Analytical grade Laboratory Reagents
were obtained from Merck.
Animals and sampling
Male Wistar Rats aged 2 months (200-225 g) were supplied with
food and water ad libitum, and exposed to a 12 h light-dark cycle.
The following groups were established: (A) rats were pretreated
intraperitonally with 0.9% NaCl daily for five days before a single
sublethal dose of TA (500 mg/Kg body weight) freshly dissolved in
0.9% NaCl. (B) rats were pretreated intraperitoneally with PB freshly
dissolved in 0.9% NaCl (80 mg/g body weight) daily for five days
before TA administration. (C), rats were pretreated with PB daily for
five days, and instead of TA, this group received NaCl 0.9%. The
control of each group refers to samples obtained at 0 h (before TA
administration in group A and B, and before NaCl administration in
group C). Each experiment was performed in duplicate from four
animals, and followed the international criteria outlined in the
«Guide for the care and use of laboratory animals» published by the
National Institutes of Health (NIH publication n.º 80-83, revised
1985).
Processing of the samples
In order to clarify the sequential changes during the different
stages of liver injury and regeneration, samples were obtained from
control (0h) and at 12, 24, 48, 72, and 96 h following TA intoxication
in groups A and B, and following NaCl in group C. Rats were
sacrificed by cervical dislocation and samples of liver were obtained
and processed as previously described (14). Blood was collected from
hearts and kept at 4ºC for 24 h, centrifuged at 3000 rpm for 15 min,
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and serum was obtained as the supernatant. Liver samples were
obtained for morphological and mitotic index analysis. Another
group of rats was used for hepatocyte isolation.
Histological study
Rat liver pieces untreated and pretreated with PB following
thioacetamide intoxication were fixed in 10% formaldehyde
embedded in paraffin, sectioned (5 µm) and stained with hematoxilin
and eosin. The mitotic index was calculated on glass slide mounted
liver sections as the ratio of number of mitosis per cell density in the
perivenous and midzonal acinar regions according to the method of
Simpson et al. (15).
Enzyme and metabolite assays
Enzyme determinations were carried out in serum and in the
microsomal fraction of the liver homogenates in the optimal
conditions of pH and temperature, and with substrates and cofactors
at saturation. Several determinations were carried out in serum of
rats: Isocitrate dehydrogenase (nm/min/ml serum) was determined
spectrophotometrically at 340 nm in the presence of isocitrate and
NADPH (16); total bilirubin (µg/ml serum) was determined
spectrophotometrically at 578 nm with sulfanilic acid diazoreagent
in the presence of caffeine (17). α-fetoprotein (ng/ml serum) was
detected by enzymatic immunoassay of particles (MEIA) as described
by Wespie (18) modified by Barnes et al. (19). Proteins were
evaluated by the method of Bradford (20).
Thiobarbituric acid reactive substances (TBARS) were expressed
as mmol/g of fresh liver. Liver pieces were homogenized in
trichloroacetic acid and the supernatant was treated with
thiobarbituric acid. Samples were heated at 90ºC for 15 min,
centrifuged and the absorbance was measured at 535 nm as
described by Niehaus and Samuelsson (21).
In the microsomal fraction of liver, obtained as previously
described (4), the activities of flavine-containing moonooxygenase
(FMO) and the O-dealkylation of pentoxiresorufin, as enzyme marker
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of cytochrome P-450 2B, were determined. FMO activity, expressed
as nmol/min/mg protein, was assayed spectrophotometrically at 420
nm by measuring the N, N-dimethylaniline oxidation (22).
Pentoxyresorufin O-dealkylase activity, expressed as pmol of
resorufin/min/mg protein, was determined as previously described
by Honkakoski and Lang (23), by measuring the formation of
resorufin using a Perkin-Elmer spectrophotofluorimeter at the
excitation and emission wavelengths of 522 and 586 nm, respectively.
Isolation of hepatocytes and flow cytometry analysis
From rats anaesthetized with 50 mg/Kg sodium pentobarbital
dissolved in 0.9% NaCl, hepatocytes were isolated by perfusion in
situ according to the classic collagenase method (24). Cell viability,
determined by tripan blue exclusion, was greater than 90%. For the
analysis of DNA content and ploidy, 1 x 106 viable cells were stained
with propidium iodide following the multistep procedure of Vindelov
et al. (25). The emitted fluorescence (FL2A) of the DNA-propidium
iodide complex was assayed in a FACS-scan flow cytometer (Becton-
Dickinson). A double discriminator module was used to distinguish
between signals coming from a single nucleus and those produced
by nuclear aggregation. Data were analyzed by evaluating single
nucleus inputs (104 nuclei/assay).
Statistical analysis
The results were calculated as the means ± SD of four
experimental observations obtained from four animals. Differences
between groups were obtained by analysis of variance followed by
Snedecor F (α = 0.05). Student t test was performed for statistical
evaluations as follows: all values against their control as (a), the PB-
pretreated group against untreated as (b). Statistical significance
was considered for p < 0.05.
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RESULTS
PB increases cell proliferation in the liver (26); and, as a result,
the ratio liver weight/body weight increases significantly. In our
experimental conditions the increase of this radio was 150% (4).
Histological study
The experimental liver toxicity was confirmed by means of
histopathology and serum assays. The histopathological study was
carried out to detect the acinar location of necrosis, and to establish
the relationship between the histopathological events and the
biochemical parameters of liver injury. Figures 1-4 show the liver
morphology observed by light microscopy in sections of 5 µm
obtained from non PB pretreated (Figure 1 & 3) or pretreated rats
(Figures 2 & 4). Figures 1 & 2 (magnification 125), corresponding to
rat liver at 24 h following TA, show the necrotic areas surrounding
the central vein, and the much more pronounced extent of these
areas in liver of PB pre-treated rats (Figure 2). The extent of the
necrotic areas was parallel to other parameters of liver injury, such
as serum alanine and aspartate aminotransferases, isocitrate
dehydrogenase or total bilirubin. PB pretreatment did not affect the
intraacinar location of necrosis.
Figures 3 & 4 show the morphology (magnification 625) of rat
liver following 48 h of TA administration. Figure 3 corresponds to
non PB pretreated liver and Figure 4 corresponds to PB-pretreated
liver. In both microphotographs, cells in mitosis are clearly visible.
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FIGURE 1-2. Effect of PB-pretreatment on liver morphology following 24 h of TA
administration. Liver slices of 5µm were obtained and stained from non PB
pretreated (Figure 1) and PB pretreated rats (Figures 2). Figures 1 & 2 correspond
to liver slices obtained at 24 h of intoxication and show the areas of necrosis
surrounding the venous terminal (x 125).
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FIGURE 3-4. Effect of PB-pretreatment on liver morphology following 48 h of
TA administration. Liver slices of 5 µm were obtained and stained from non
PB pretreated (Figure 3) and PB pretreated rats (Figures 4). Figures 3 & 4
correspond to liver slices obtained at 48 h of intoxication and show cells
in mitosis (M) (x 625).
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Mitotic Index (MI)
Mitotic index (MI) is defined as the ratio between cells in mitosis
and total cells (15). MI, as a marker of cellular proliferation, was
determined on slices of 5 µm obtained from rat liver. Slices were
stained with hematoxilin and eosin and cells were observed and
mitosis quantified under a light microscope. MI was calculated as
the number of mitosis against the total number of cells by analyzing
the perivenous area of the hepatic acinus. The highest index of
proliferation was located in the vicinity of the necrotic region.
The results obtained by counting the cells in mitosis against total
cells are shown in Table 1 and are expressed as MI x 103. As
hepatocytes from control rats (without treatment) were in the
quiescent state, mitosis was very low and MI was undetectable.
However, in the case of TA-treated livers, when the peak of cell
proliferation was reached at the time point of 48 h of intoxication,
the values obtained were 53 ± 3 and 80 ± 6 for non-pretreated and
PB-pretreated, respectively. The differences against control were
statistically significant. From this time point a progressive decrease
was observed in the MI that was still detectable at 96 h of TA
administration. PB-pretreatment, without TA, induced a detectable
MI, but this effect disappeared progressively when PB was no longer
administered.
TABLE 1. Effect of PB-pretreatment on mitotic index (MI) in liver slices of rats
at 0, 12, 24, 48, 72 and 96 h following TA administration
Time (h)
PB TA PB + TA
MI x 103
0 2 ± 0.3 Undetectable 2 ± 0.2
12 1 ± 0.1 Undetectable 1 ± 0.1
24 1 ± 0.1 Undetectable 2 ± 0.2
48 Undetectable 53 ± 3 a 80 ± 6 ab
72 Undetectable 46 ± 4 a 60 ± 6 ab
96 Undetectable 11 ± 1 a 17 ± 2 ab
Mitotic index (MI) was calculated as the ratio of number of mitosis per cell
density, according to the method of Simpson et al. (1992). Data expressed as
means ± SD are mean of 15 values, either the number of cells or the number
of mitosis. Statistics were (a) values against control; (b) PB + TA against TA.
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Serum parameters of thioacetamide hepatotoxicity
One of the symptoms of liver necrosis is the appearance in serum
of hepatic enzymes. Isocitrate dehydrogenase (ICDH) is an NADPH
generating enzyme mainly located in the perivenous area of the
hepatocytes. ICDH activity is used as a parameter of hepatocellular
damage to measure the severity of centrilobular necrosis in vivo.
Serum ICDH is the best marker for perivenous necrosis since
aspartate and alanine aminotransferases are mainly located in
the periportal space (27). The effect of PB pre-treatment in ICDH
activity on rat serum obtained at 0, 12, 24, 48, 72 & 96 h after
TA administration is shown in Figure 5. The peak of enzyme
activity in both groups, PB untreated or PB pretreated, was observed
at 24 h, but in the case of PB-pretreated samples a significant
increase was detected, which indicates that the extent of necrosis
induced by thioacetamide was markedly increased by the effect
of PB-pretreatment. This enhanced severity of TA-induced injury by
the effect of PB was also described in previous results from our
group (4) and from others (28).
FIGURE 5. Effect of PB pre-treatment on ICDH activity in rat serum. Samples of
blood were obtained from rats untreated or pretreated with PB at 0, 12, 24, 48, 72
and 96 h following TA administration. Results are expressed as nmol per min per
ml of serum and are the mean ± SD of four experimental determinations from
four rats. Statistics were (a) values against control; (b) PB + TA against TA.
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The levels of total bilirubin (µg/ml) in serum obtained from PB
untreated and PB-pretreated rats were determined at 0, 12, 24, 48,
72 and 96 h following TA administration. The release of bilirubin to
serum is a marker of liver disease. In our experiments the levels of
bilirubin increased markedly with a profile parallel to that obtained
for ICDH activity, although the peak of serum bilirubin when
compared to that of ICDH was delayed, and appeared at 48 h of
intoxication (Figure 6).
FIGURE 6. Effect of PB pre-treatment on the levels of total bilirubin in rat serum.
Samples of blood were obtained from rats untreated or pretreated with PB at 0,
12, 24, 48, 72 and 96 h following TA administration. Results are expressed as
mg/100 ml of serum and are the mean ± SD of four experimental determinations
from four rats. Statistics were (a) values against control; (b) PB + TA against TA.
The concentration of α-fetoprotein (AFP), expressed as ng/ml was
assayed on serum of rats that underwent or not a PB pre-treatment
at 0, 12, 24, 48, 72 and 96 h following TA (Figure 7). AFP is a
glycoprotein whose gene expression occurs in the yolk sac, in the
fetal liver and gut and in the adult liver during regeneration and
tumorigenesis (29). Our results show that a significant increase in
AFP was detected in rat serum at 12 h of TA intoxication, which
remained high until 72 h. In serum of PB-pretreated rats the increase
in AFP following TA was higher and remained high until 96 h of
intoxication.
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FIGURE 7. Effect of PB pre-treatment on the levels of α-fetoprotein in serum of
rats. Samples of blood were obtained from rats untreated or pretreated with PB at
0, 12, 24, 48, 72 and 96 h following TA administration. Results are expressed as
ng/ml of serum and are the mean ± SD of four experimental determinations from
four rats. Statistics were (a) values against control; (b) PB + TA against TA.
An enhancement in the concentration of TBARS is a marker of
oxidative stress and lipoperoxidation, which is a consequence of drug
metabolism. Figure 8 shows the levels of TBARS determined in liver
homogenates of rats at 0, 12, 24, 48, 72 and 96 h of TA administration
either in PB untreated or pretreated rats. TBARS increased
significantly at 24 of intoxication. In PB-pretreated liver, the levels
of TBARS levels were higher and differences against untreated were
significant.
FIGURE 8. Effect of PB pre-treatment on the levels of TBARS concentration in
rat liver homogenates. Samples of liver were obtained from rats untreated or
PB-pretreated animals at 0, 12, 24, 48, 72 and 96 h following TA administration.
Results are expressed as µmol/g of liver and are the means ± SD of four
experimental observations from four rats. Statistics were (a) values against
control; (b) PB + TA against TA.
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FIGURE 9. Effect of PB pre-treatment on the activity of FMO in rat liver
homogenates. Samples of liver were obtained from rats untreated or PB-pretreated
animals at 0, 12, 24, 48, 72 and 96 h following TA administration. Results are
expressed as nmol/min/mg of protein and are the means ± SD of four
experimental observations from four rats. Statistics were (a) values against
control; (b) PB + TA against TA.
Parameters related to thioacetamide oxidative metabolism
As TA is not toxic per se, its intermediary metabolism is
obligatory for its hepatotoxicity. Microsomal monooxygenases are
responsible for its oxidation in sulfoxide and sulfone derivatives.
In a previous study of our group, it was demonstrated that the
basal activity of FMO underwent age-related changes (11, 30).
After TA administration FMO activity was induced as early as at
12 h of intoxication preceding the peak of necrosis, and the peak
of lipoperoxidation. Figure 9 shows the activity of this enzyme
system (nmol/min/mg protein), which underwent biphasic changes
showing a marked decrease at 24 h, just at the time point of ne-
crosis. Necrosis destroyed the perivenous area, the area where FMO
is mainly located. PB-pretreatment markedly increased the activity
of this enzyme system and the increase was detected even in samples
of control livers.
Figure 10 shows the effect of PB pre-treatment on O-dealkylation
of pentoxiresorufin expressed as pmol/min/mg protein, determined,
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as a marker of CYP 2B activity, in the microsomal fraction of
homogenates from rat liver obtained at 0, 12, 24, 48, 72 and 96 h
following TA administration. In the experimental conditions of the
present study, PB pretretment increased by more than six fold the
activity of this enzyme. However, this enhanced activity decreased at
12 and 24 h of PB withdrawal when TA was not administered, in
such way that at 48 h the levels reached the basal values (data not
shown). TA by itself did not exert any effect on this enzyme activity.
FIGURE 10. Effect of PB pretreatment on the O-dealkylation of pentoxiresorufin
in rat liver homogenates. Samples of liver were obtained from rats untreated or
PB-pretreated animals at 0, 12, 24, 48, 72 and 96 h following TA administration.
Results are expressed as pmol/min/mg protein and are the means ± SD of four
experimental observations from four rats. Statistics were (a) values against
control; (b) PB + TA against TA.
Flow Cytometric Analysis
The sequence of post-necrotic proliferation of hepatocytes was
also detected in isolated liver cells at different time points (0, 3, 12,
24, 48, 72 and 96 h) following thioacetamide, by measuring the ploidy
and DNA distribution in the cell cycle phases. In DNA histograms
(Figure 11) the values are expressed as the relative number of cells
against the fluorescence (FL2A) emitted by the propidium iodide-
DNA complex, obtained by flow cytometry. In Figure 12 is shown the
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FIGURE 11. Histograms of DNA content and ploidy by flow cytometry. The relative
number of stained cells (vertical axis) was plotted against DNA ploidy. 2C for
diploid, 4C for tetraploid and 8C for octoploid populations (horixontal axis). To
follow the time course of alterations in genomic DNA distribution, hepatocytes
were obtained from PB untreated or pretreated at 0, 3, 12, 24, 48, 72 and 96 h
following TA. Isolated and trypsinized hepatocytes were processed as indicated in
the kit kinesis for distribution of DNA in the cell populations in the cell cycle.
Quantitave analysis is shown in Figure 12.
quantification of the DNA histograms relative to the hepatocyte
populations: diploid (2C), poliploid (4C + 8C) and in phase of DNA
synthesis, S1 (G1 ! G2) + S2 (G2 ! G4). Remarkable changes were
obtained at 48 h, such as a 12 (TA) and 17 (PB + TA) fold increase
in DNA synthesis and parallel but opposite changes in diploid and
tetraploid populations. 4C diminished parallel to the increase in
2C. The peak of hepatocellular regeneration was at 48 h, when the
highest synthesis of DNA was detected, and at this moment the ploidy
profile appeared equal to that of fetal hepatocytes.
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FIGURE 12. Quantitave analysis of DNA histograms in Figura 11. (A) diploid (2C)
population; (B) cells synthesizing DNA and (C) tetraploid and octoploid
populations (4C + 8C). Results are expressed as percentage of total are the means
± SD of four experimental observations from four rats. Statistics were (a) values
against control; (b) PB + TA against TA.
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DISCUSSION
In response to the action of hepatotoxic drugs, the liver develops
hepatocellular necrosis, which is immediately followed by
hepatocellular regeneration and restoration of the liver function (31-
33). In the present investigation the effect of a previous treatment
with PB was assayed on liver necrosis and hepatocellular
regeneration induced by TA. The location of the liver injury induced
by TA in the perivenous acinar region is caused by the higher
abundance of smooth endoplasmic reticulum in this area and the
greater ability to oxidize xenobiotics and to produce reactive
intermediates. The extent of the necrotic area was larger in the case
of PB-pretreatment, but the intraacinar location of injury apparently
did not change. It is well known that PB induces the proliferation
of the smooth endoplasmic reticulum, which is mainly located
in the perivenous area (34). PB has the ability to induce the
expression of several isozymes of the cytochrome P450-dependent
microsomal system, such as P450 2B. One aim of this study was
to evaluate the interaction between PB and TA, against the
hepatocellular damage and post-necrotic hepatocyte proliferation.
TA is a well known necrogenic agent, which is apparently
metabolized by the FMO (35, 36). The necrogenicity of TA is a
consequence of its biotransformation in free radical derivatives, by
the microsomal monooxygenases mentioned previously. As PB
induces the proliferation of the smooth endoplasmic reticulum, it
may also induce all the microsomal systems that are attached to
their membranes such as FMO and CYP. PB also induces the
expression of drug metabolizing enzymes, mainly those that are
cytochrome P 450 2B dependent. This induction affects drug
metabolism and clearance, drug toxicity and carcinogenicity (26).
The results obtained by our group in the present and previous
studies demonstrate that PB pretreatment increases FMO activity.
The higher degree of necrosis induced by PB-pretreatment may be
due to the enhancement of enzyme activities of both FMO and
CYP2B. The contribution of each of these two systems to TA
metabolism, needs to be clarified in future studies at the level of
transcription and translation by using specific inhibitors.
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Analyzed in the present study was the influence of PB on TA-
induced liver injury and regeneration both at morphological and at
flow cytometric levels. On liver slices of 5 µm stained with
hematoxilin & eosin, the following observations were made: first,
that PB-pretratment does not modify the intraacinar location of the
necrotic area induced by TA, which indicates that the microsomal
monooxygenase system responsible for TA biotransformation are
selectively located in the perivenous region. Other hepatotoxic agents,
such as cocaine, when administered to PB-pretreated mice, the
location of liver injury shift rom the perivenous to the periportal
area (3). Second, that PB-pretreatment increases the severity of the
damage, which can be clearly observed in Figures 1 & 2, obtained by
light microspopy. As TA is not toxic per se, the increase in the extent
of toxicity demonstrates that the microsomal systems, responsible
for its oxidative metabolism, are induced by PB-pretreatment (4).
These results are in agreement with those obtained in serum as
parameters of necrosis. The assay of serum isocitrate dehydrogenase
showed that the time point of maximum necrosis appeared at 24 h
following thioacetamide in both experimental groups: TA and
PB + TA. However, the extent of damage was significantly more
pronounced in the PB-pretreated group. Other parameters of liver
injury, such as bilirubin and TBARS, showed parallel results.
Liver regeneration is an essential process that permits the repair
of the hepatic tissue and the restoration of liver function following
liver injury or surgical resection. In our experiments, the extent
of liver regeneration induced by TA was parallel to the severity of
liver injury. By flow cytometry was determined the distribution
of hepatocyte populations with respect to DNA ploidy and DNA
synthesis. Population in S phase peaked at 48 h of intoxication, both
in PB untreated and pretreated groups. These results agree with
those obtained by counting the mitosis as mitotic index. Our results,
obtained by flow cytometry, permitted us to detect, not only the
population that undergoes DNA replication, but also the various
stages of cell proliferation: G1 (2C) and G2 (4C + 8C). In this way it
can be observed that when regeneration processes starts, diploid
population increases, while tetraploid and octoploid decreases (10),
and the profile of liver cell ploidy appears similar to that found in
fetal hepatocytes. PB-pretreatmet not only increased DNA synthesis
DAVID ANDRÉS Y COLS. AN. R. ACAD. NAC. FARM.
654
but also affected the other stages of the cell cycle. AFP levels, another
parameter related to the proliferative state of the cell, underwent
significant changes due to PB-pretreatment.
On the basis of the present results, it is concluded that PB
administration to rats previous to TA intoxication, potentiates the
hepatotoxicity and the post-necrotic response induced by TA, but
has no influence on the location of the intraacinar injury. The
recovery of organisms suffering from severe liver damage depends
heavily on the ability of the remaining hepatocytes to proliferate and
replace the liver function. Death of the organism usually occurs when
the regenerating ability of the liver is compromised owing to heavy
damage to the liver. The current approach to therapy aims only to
block additional liver injury from hepatotoxicants or hepatic disease.
If hepatocellular regeneration and tissue repair could be stimulated
after hepatic damage by a therapeutically compatible mechanism,
the prevention of death arising from serious liver damage is a distinct
possibility.
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